期刊
NEUROPATHOLOGY AND APPLIED NEUROBIOLOGY
卷 43, 期 3, 页码 194-199出版社
WILEY
DOI: 10.1111/nan.12378
关键词
Alzheimer's disease; biomarker; cerebrospinal fluid; plasma; tau
资金
- Swedish Research Council, Swedish State Support for Clinical Research
- European Research Council
- Wolfson Foundation and Frimurarestiftelsen
- Wallenberg Academy Fellow
Tau is a microtubule-binding protein that is important for the stability of neuronal axons. It is normally expressed within neurons and is also secreted into the brain interstitial fluid that communicates freely with cerebrospinal fluid (CSF) and, in a more restricted manner, blood via the glymphatic clearance system of the brain. In Alzheimer's disease (AD), neuroaxonal degeneration results in increased release of tau from neurons. Furthermore, tau is truncated and phosphorylated, which leads to aggregation of tau in neurofibrillary tangles of the proximal axoplasm. Neuroaxonal degeneration and tangle formation are reflected by increased concentrations of total tau (T-tau, measured using assays that detect most forms of tau) and phospho-tau (P-tau, measured using assays with antibodies specific to phosphorylated forms of tau). In AD CSF, both T-tau and P-tau concentrations are increased. In stroke and other CNS disorders with neuroaxonal injury but without tangles, T-tau is selectively increased, whereas P-tau concentration often stays normal. In tauopathies (diseases with both neurodegeneration and neurofibrillary tangles) other than AD, CSF T-tau and P-tau concentrations are typically unaltered, which is a puzzling result that warrants further investigation. In the current review, I discuss the association of T-tau and P-tau concentrations in body fluids with neuropathological changes, imaging findings and clinical features in AD and other CNS diseases. The search for reliable biomarkers for neurodegenerative diseases is an active field, important for diagnosis, monitoring disease progression and treatment response. This focussed review by Professor Zetterberg considers the association of total tau and phospho-tau in body fluids with neuropathology, imaging and clinical features in Alzheimer's disease (AD) and other neurodegenerative diseases.
作者
我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。
推荐
暂无数据